These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30046902)

  • 1. Understanding the interactions of diruthenium anticancer agents with amino acids.
    Nazarov AA; Mendoza-Ferri MG; Hanif M; Keppler BK; Dyson PJ; Hartinger CG
    J Biol Inorg Chem; 2018 Oct; 23(7):1159-1164. PubMed ID: 30046902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
    Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
    Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.
    Hu W; Luo Q; Ma X; Wu K; Liu J; Chen Y; Xiong S; Wang J; Sadler PJ; Wang F
    Chemistry; 2009 Jul; 15(27):6586-94. PubMed ID: 19533706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.
    Chen F; Romero-Canelón I; Habtemariam A; Song JI; Banerjee S; Clarkson GJ; Song L; Prokes I; Sadler PJ
    Dalton Trans; 2022 Mar; 51(11):4447-4457. PubMed ID: 35226015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
    Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
    Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
    Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer cell growth by ruthenium(II) arene complexes.
    Morris RE; Aird RE; Murdoch Pdel S; Chen H; Cummings J; Hughes ND; Parsons S; Parkin A; Boyd G; Jodrell DI; Sadler PJ
    J Med Chem; 2001 Oct; 44(22):3616-21. PubMed ID: 11606126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
    Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG
    Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties.
    Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ
    Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
    Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
    J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.
    Zhao J; Li S; Wang X; Xu G; Gou S
    Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecule binding vs. anticancer activity: reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins.
    Meier SM; Hanif M; Kandioller W; Keppler BK; Hartinger CG
    J Inorg Biochem; 2012 Mar; 108():91-5. PubMed ID: 22420927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug development.
    Babak MV; Meier SM; Legin AA; Adib Razavi MS; Roller A; Jakupec MA; Keppler BK; Hartinger CG
    Chemistry; 2013 Mar; 19(13):4308-18. PubMed ID: 23341078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.